AB0456 HYDROXYCHLOROQUINE MIGHT REDUCE MORTALITY IN PATIENTS WITH SYSTEMIC SCLEROSIS
Mustafa Özmen, E. Otman Akat, Sercan Gücenmez, G. Kabadayi, E. Durak Ediboglu, Gülay Alp, H. Cinakli, E. Erpek, İ. Kurut Aysin, Ö. Bayındır, Dilek Solmaz, Servet Akar
Topics & Concepts
MedicineInternal medicineHydroxychloroquineInterstitial lung diseaseProportional hazards modelRetrospective cohort studyRheumatologyDiseaseMedical recordLungCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)Systemic Sclerosis and Related DiseasesMedical Imaging and Pathology StudiesInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis